Rezo Therapeutics
Greg Friedland, Ph.D., is a seasoned engineer and scientist with extensive experience in software engineering and computational science. Currently serving as Principal Engineer at Rezo Therapeutics, Greg has held key positions at companies such as Atomwise, Autodesk, and Nodality Inc., including Senior Principal Software Engineer and Head of Software Engineering. Greg's academic background includes a Ph.D. in Biophysics from the University of California, San Francisco, and a B.A. in Physics & Computer Science from Dartmouth College.
Rezo Therapeutics
Rezo is a different kind of biopharma company. Our mission is to dramatically increase the success rate of drug development by building a disease-agnostic, fully-integrated, network biology platform that will redefine our understanding of human disease and ability to treat it.